Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Onco LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 38.00p 36.00p 40.00p 38.00p 38.00p 38.00p 11,385 05:00:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Investment & Services 0.0 -16.5 -17.6 - 64.44

Advanced Onco Share Discussion Threads

Showing 5001 to 5025 of 5350 messages
Chat Pages: Latest  202  201  200  199  198  197  196  195  194  193  192  191  Older
DateSubjectAuthorDiscuss
16/2/2018
09:28
Selling? What? This is an incredible share price, in my humble opinion 100p plus very soon.
paul_98
16/2/2018
09:03
I studied Physics at UCL and my favorite subject was atomic physics. I can tell you that the technology they are developing has massive implication. My professors were working at CERN and i think this company has hit the JACKPOT! I will be visiting my university next week and speaking to professors regarding this company and its technology.
jayj4u
16/2/2018
08:37
It will. This will,IMO, not all be happening without massive inside knowledge of the progress. SO POSITIVE!!! Yes!
paul_98
16/2/2018
08:24
It is good news but I still remain cautious. A lot depends on the technology being fully developed to the timeline promised by the BoD so that production can go ahead.
daijavu
16/2/2018
07:34
THIS IS THE MOST IMPORTANT PART!!!! Yantai Cipu has also informed the Company that they are in advanced negotiation with a major medical equipment and pharmaceutical distribution company in China for a collaboration to accelerate and strengthen their market access in the People's Republic of China, Hong Kong, Macau, Taiwan and South Korea (the "Territories"). The Company and Yantai Cipu have agreed that it is in the best interest of the Company and its shareholders to extend the Long Stop Date for the Distribution Agreement until 31 March 2018 to enable the satisfactory completion of the negotiations with the new participant. The commitment of Yantai Cipu vis-à-vis the Distribution Agreement is unchanged, and the receipt of the GBP16,500,000 payment from Yantai Cipu relating to the commercial agreement with Yantai Cipu also announced on 7 December 2017 is not conditional on the completion of negotiations with the distribution company.
jayj4u
16/2/2018
07:16
RNS Number : 0737F Advanced Oncotherapy PLC 16 February 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Completion of the Subscription Agreement Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that in relation to the announcement dated 7 December 2017 and following the passing of the resolution proposed for the vote of the Company' shareholders on 23 January 2018, the Company has been informed by Yantai Cipu that the Chinese authorities have authorised the transfer from China of the GBP13,500,000 payable by Yantai Cipu for the subscription for 45,000,000 new ordinary shares of GBP0.25 each to be issued by the Company to Yantai Cipu (the "Subscription") at GBP0.30 per share (the "Subscription Price"). As a consequence of the completion of the Subscription by Yantai Cipu, and as detailed in the circular dated 22 December 2017 (the "Circular"), the placing of 10,868,782 new ordinary shares with new and existing investors at the Subscription Price (the "Placing"), as well as the conversion of the loan made by Swedish Investors by way of issue of 13,697,697 new ordinary shares (the "Conversion"), have also been completed. Application has been made for admission to trading on AIM ("Admission") of the 69,566,479 new ordinary shares deriving from the Subscription, the Placing and the Conversion and it is expected that Admission will occur on or around 22 February 2018. Following Admission, the total number of ordinary shares in issue will be 150,501,673 and Yantai Cipu will hold 29.90% of the enlarged issued share capital of the Company. Yantai Cipu has also informed the Company that they are in advanced negotiation with a major medical equipment and pharmaceutical distribution company in China for a collaboration to accelerate and strengthen their market access in the People's Republic of China, Hong Kong, Macau, Taiwan and South Korea (the "Territories"). The Company and Yantai Cipu have agreed that it is in the best interest of the Company and its shareholders to extend the Long Stop Date for the Distribution Agreement until 31 March 2018 to enable the satisfactory completion of the negotiations with the new participant. The commitment of Yantai Cipu vis-à-vis the Distribution Agreement is unchanged, and the receipt of the GBP16,500,000 payment from Yantai Cipu relating to the commercial agreement with Yantai Cipu also announced on 7 December 2017 is not conditional on the completion of negotiations with the distribution company. The receipt of funds in relation to the commercial agreement is subject to approval from the Government of the People's Republic of China for the transfer of monies to the United Kingdom. Lancea LLP advised the Company on the Subscription and Distribution agreements made by Yantai Cipu. For further information, please contact:
jayj4u
14/2/2018
09:14
Very quiet chat forum! Any thoughts out there on this?
paul_98
09/2/2018
16:50
Solid end to this week. Considering world markets we can feel good here. GLA.
paul_98
09/2/2018
09:27
Good point. I would have hoped for some sort of update on this progress.
paul_98
09/2/2018
08:31
Hi Paul I would hope monies will be received soon especially with Chinese New Year upon us the end of next week which will basically be then a 2 week shut down. I would be very surprised if it is not before this time.
makeamillion1
09/2/2018
07:42
Any thoughts?
paul_98
03/2/2018
07:11
Any indication of when the Chinese money will arrive?
paul_98
29/1/2018
07:21
Much further down the line now, tech, Harley Street, de-risked. I don't see it as the same at all. Some do obviously which is fine. Much, much better situation now. More solid in many ways. IMO.
paul_98
29/1/2018
00:54
Paul. It was exactly the same before the share price tanked two years ago. The money was secured, according to the BoD, the tech was on target even though it wasn't, directors were investing heavily, there was a huge market and AVO had even won multiple contracts in China which it went on to lose. I am waiting to see if it really is different now.
daijavu
24/1/2018
10:16
Resolutions passed, money secured. Is awaiting arrival, tech on target, directors invested heavily, huge market yet people are selling?!
paul_98
24/1/2018
08:29
I am not sure the chinese money have landed in UK yet? Once they have - the shares should move on very nicely, no doubt.
baner
24/1/2018
08:01
So now they go ahead and have the funding transferred? Great! What a year ahead.
paul_98
23/1/2018
22:03
All resolutions passed so seems to be on track and doing well, haven't heard or seen anything otherwise.Matter of time till we are at 100 imo
adealsiddiq110
23/1/2018
21:23
Any info to glean?
paul_98
22/1/2018
16:53
Yes, positives all the way for my money.
paul_98
22/1/2018
15:06
According to my calendar it's the General meeting tomorrow. Any thoughts?
adealsiddiq110
19/1/2018
10:25
Starting to bubble nicely again.
paul_98
18/1/2018
15:32
if the deal with the chinese is confirmed - i.e they have the funds tranferred from china and on to AVO, then i certainly believe the shares will move on north - 100p+ should clearly be a realistic objective for 2018.
baner
18/1/2018
09:44
Is this likely to break through 60 after the GM?
paul_98
12/1/2018
08:27
More Director buying. Excellent, reassuring RNS.
paul_98
Chat Pages: Latest  202  201  200  199  198  197  196  195  194  193  192  191  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20181022 12:44:54